Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» imsidolimab
imsidolimab
AnapstysBio’s imsidolimab Phase III trial’s results can bring it closer to approval
Clinical Trials Arena
Tue, 10/31/23 - 11:26 am
AnaptysBio
clinical trials
generalized pustular psoriasis
imsidolimab
Chasing Boehringer, Anaptys hits goal in pivotal rare skin disease trial, plans out-licensing deal
Fierce Biotech
Mon, 10/9/23 - 10:11 am
AnaptysBio
generalized pustular psoriasis
clinical trials
imsidolimab
Boehringer Ingelheim
AnaptysBio's HARP plays dud note, prompting rethink of imsidolimab strategy
Fierce Biotech
Thu, 09/1/22 - 10:46 am
AnaptysBio
imsidolimab
hidradenitis suppurativa
AnaptysBio gets double downgrade at JPM after Imsidolimab trial failure
Seeking Alpha
Tue, 03/9/21 - 10:55 am
AnaptysBio
imsidolimab
clinical trials
palmoplantar pustulosis